Premium
MAINTENANCE RITUXIMAB IMPROVES SURVIVAL IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA PATIENTS: ANALYSIS OF THE CZECH LYMPHOMA STUDY GROUP
Author(s) -
Obr A.,
Klener P.,
Belada D.,
Pytlik R.,
Simkovic M.,
Salek D.,
Mocikova H.,
Prochazka V.,
Janikova A.,
Markova J.,
Campr V.,
Kodet R.,
Trneny M.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_69
Subject(s) - medicine , rituximab , mantle cell lymphoma , regimen , international prognostic index , cytarabine , surgery , lymphoma , gastroenterology , chop , oncology , chemotherapy